Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Hiddensecretson Jan 22, 2021 10:28am
245 Views
Post# 32358810

Next week: Bought deal closed + possible news on cubes....

Next week: Bought deal closed + possible news on cubes....Next week the $ 5 million bought  deal closes on January 26th.

Stocks often rally after a bought deal or PP is closed as it means company is well financed to fund expansion for growth and therefore stock is de-risked from its previous level.

I also see an avalanche of openings once company has funds in the bank account.  Growth probably held back a little because of having to fund payroll of hundreds of people on a regular basis, especially when insurance companies take 60 days o 90 days to pay bill.    The $ 5 million is in essence like a bridge loan, but that is not payable back.

We opened 9 cubes this week so growth is ACCELERATING.

Canaccord will bring in their investors, a buy rating, which will put MEDV on the map with other analysts and expand our exposure, which in turn will bring in more investors from other firms and more upgrades from other institutions.

In March 2021, we can realistically expect the $ 1.9 trillion budget to pass where we become beneficiares of the Biden pie of $ 50 billion in testing. 

Therefore plenty of catalysts and as I stated earlier, no where near fair market value.    

MPO

<< Previous
Bullboard Posts
Next >>